- Home
- AMZE vs BRTX Comparison
AMZE vs BRTX Comparison
Compare AMZE & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMZE
- BRTX
- Stock Information
- Founded
- AMZE 2019
- BRTX 1997
- Country
- AMZE United States
- BRTX United States
- Employees
- AMZE N/A
- BRTX N/A
- Industry
- AMZE Beverages (Production/Distribution)
- BRTX Managed Health Care
- Sector
- AMZE Consumer Staples
- BRTX Health Care
- Exchange
- AMZE Nasdaq
- BRTX Nasdaq
- Market Cap
- AMZE 12.3M
- BRTX 12.5M
- IPO Year
- AMZE 2021
- BRTX N/A
- Fundamental
- Price
- AMZE $1.87
- BRTX $1.62
- Analyst Decision
- AMZE
- BRTX
- Analyst Count
- AMZE 0
- BRTX 0
- Target Price
- AMZE N/A
- BRTX N/A
- AVG Volume (30 Days)
- AMZE 140.7K
- BRTX 78.1K
- Earning Date
- AMZE 11-13-2025
- BRTX 11-11-2025
- Dividend Yield
- AMZE N/A
- BRTX N/A
- EPS Growth
- AMZE N/A
- BRTX N/A
- EPS
- AMZE N/A
- BRTX N/A
- Revenue
- AMZE $1,054,111.00
- BRTX $605,200.00
- Revenue This Year
- AMZE $6,741.66
- BRTX $232.67
- Revenue Next Year
- AMZE $100.61
- BRTX $52.92
- P/E Ratio
- AMZE N/A
- BRTX N/A
- Revenue Growth
- AMZE N/A
- BRTX 247.62
- 52 Week Low
- AMZE $1.57
- BRTX $1.19
- 52 Week High
- AMZE $28.72
- BRTX $2.55
- Technical
- Relative Strength Index (RSI)
- AMZE 37.03
- BRTX 59.13
- Support Level
- AMZE $1.96
- BRTX $1.56
- Resistance Level
- AMZE $2.12
- BRTX $1.73
- Average True Range (ATR)
- AMZE 0.46
- BRTX 0.11
- MACD
- AMZE -0.04
- BRTX 0.03
- Stochastic Oscillator
- AMZE 12.50
- BRTX 80.81
About AMZE Amaze Holdings Inc. Common Stock
Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.